Home/Filings/4/0001437749-21-022776
4//SEC Filing

Berger Mark Stanley 4

Accession 0001437749-21-022776

CIK 0001595248other

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 4:26 PM ET

Size

5.3 KB

Accession

0001437749-21-022776

Insider Transaction Report

Form 4
Period: 2021-09-27
Berger Mark Stanley
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-09-27+550,000550,000 total
    Exercise: $2.85From: 2022-09-27Exp: 2031-09-27Common Stock (550,000 underlying)
Footnotes (2)
  • [F1]The options were granted outside of the Registrant's incentive award plans as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4).
  • [F2]One-third of the options will vest on each of the first, second and third anniversaries of the date on which the Reporting Person commences employment with the Registrant.

Issuer

Genprex, Inc.

CIK 0001595248

Entity typeother

Related Parties

1
  • filerCIK 0001700283

Filing Metadata

Form type
4
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:26 PM ET
Size
5.3 KB